1. Home
  2. SEEL

SEEL

Seelos Therapeutics Inc.

Logo Seelos Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 2:17pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.

Founded: 2016 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 6.0M IPO Year: N/A
Target Price: $75.00 AVG Volume (30 days): 443.2K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.73 EPS Growth: N/A
52 Week Low/High: $0.37 - $49.80 Next Earning Date: 05-13-2024
Revenue: $2,203,000 Revenue Growth: N/A
Revenue Growth (this year): -86.11% Revenue Growth (next year): 9366.67%

Share on Social Networks: